JPMorgan Funds - Global Healthcare Fund A (acc) - EURRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 19.3 | 12.7 | 1.7 | -3.1 | 5.3 | |
+/-Cat | 1.9 | 3.3 | 6.4 | 0.0 | 0.8 | |
+/-B’mrk | - | -5.5 | -4.1 | -0.6 | -3.0 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 04/10/2024 | EUR 292.82 | |
Day Change | -0.55% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU0880062913 | |
Fund Size (Mil) 04/10/2024 | USD 4302.18 | |
Share Class Size (Mil) 04/10/2024 | EUR 411.67 | |
Max Initial Charge | - | |
Ongoing Charge 18/07/2024 | 1.70% |
Investment Objective: JPMorgan Funds - Global Healthcare Fund A (acc) - EUR |
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Dominic Valder 05/10/2022 | ||
Bartjan van Hulten 28/02/2024 | ||
Inception Date 01/02/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPMorgan Funds - Global Healthcare Fund A (acc) - EUR | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
UnitedHealth Group Inc | Healthcare | 9.26 |
Eli Lilly and Co | Healthcare | 9.25 |
Novo Nordisk A/S Class B | Healthcare | 6.25 |
AbbVie Inc | Healthcare | 5.55 |
AstraZeneca PLC | Healthcare | 5.22 |
Increase Decrease New since last portfolio | ||
JPMorgan Funds - Global Healthcare Fund A (acc) - EUR |